|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013显示文摘 | Marie Ng Tom Fleming Margaret Robinson Blake Thomson Nicholas Graetz Christopher Margono Erin C Mullany Stan Biryukov Cristiana Abbafati Semaw Ferede Abera Jerry P Abraham Niveen M E Abu-Rmeileh Tom Achoki Fadia S AlBuhairan Zewdie A Alemu Rafael Alfonso | 2014 | The Lancet2014，，： | 7 |
| 2 | Clinical outcomes following salvage Gamma Knife radiosurgery for recurrent glioblastoma显示文摘Glioblastoma multiforme(GBM) is the most common malignant primary brain tumor with a survival prognosis of 14-16 mo for the highest functioning patients. Despite aggressive, multimodal upfront therapies, the majority of GBMs will recur in approximately six months. Salvage therapy options for recurrent GBM(r GBM) are an area of intense research. This study compares recent survival and quality of life outcomes following Gamma Knife radiosurgery(GKRS) salvage therapy. Following a Pub Med search for studies usingGKRS as salvage therapy for malignant gliomas, nine articles from 2005 to July 2013 were identified which evaluated rG BM treatment. In this review, we compare overall survival following diagnosis, overall survival following salvage treatment, progression-free survival, time to recurrence, local tumor control, and adverse radiation effects. This report discusses results for rG BM patient populations alone, not for mixed populations with other tumor histology grades. All nine studies reported median overall survival rates(from diagnosis, range:16.7-33.2 mo; from salvage, range:9-17.9 mo). Three studies identified median progression-free survival(range:4.6-14.9 mo). Two showed median time to recurrence of GBM. Two discussed local tumor control. Six studies reported adverse radiation effects(range:0%-46% of patients). The greatest survival advantages were seen in patients who received GKRS salvage along with other treatments, like resection or bevacizumab, suggesting that appropriately tailored multimodal therapy should be considered with each rG BM patient. However, there needs to be a randomized clinical trial to test GKRS for rG BM before the possibility of selection bias can be dismissed. | Erik W Larson Halloran E Peterson Wayne T Lamoreaux Alexander R MacKay Robert K Fairbanks Jason A Call Jonathan D Carlson Benjamin C Ling John J Demakas Barton S Cooke Christopher M Lee | 2014 | World Journal of Clinical Oncology2014，5，2： | 5 |
| 3 | Evolution of endovascular mechanical thrombectomy for acute ischemic stroke显示文摘Acute ischemic stroke(AIS) is a common medical problem associated with significant morbidity and mortality worldwide. A small proportion of AIS patients meet eligibility criteria for intravenous thrombolysis(IVT) with recombinant tissue plasminogen activator, and its efficacy for large vessel occlusion is poor. Therefore, an increasing number of patients with AIS are being treated with endovascular mechanical thrombectomy when IVT is ineffective or contraindicated. Rapid advancement in catheter-based and endovascular device technology has led to significant improvements in rates of cerebral reperfusion with these devices. Stentrievers and modern aspiration catheters have now surpassed earlier generation devices in the degree and rapidity of revascularization. This progress has been achieved with no concurrent increase in risk of major complications or mortality, both when used alone or in combination with IVT. The initial randomized controlled trials comparing endovascular therapy to IVT for AIS failed to show superior outcomes with endovascular treatment, butkey limitations of each trial may limit the significance of these results to current practice. While endovascular devices and operator experience continue to evolve, we are optimistic that this will be accompanied by improvements in patient outcomes. This review highlights the major endovascular devices used in current practice and the trials which have investigated their efficacy. | Colin J Przybylowski Dale Ding Robert M Starke Christopher R Durst R Webster Crowley Kenneth C Liu | 2014 | World Journal of Clinical Cases2014，2，11： | 2 |
| 4 | Japanese species of the Genus Stigmella(Nepticulidae;Lepidoptera)显示文摘 | | 1985 | Insecct Matsumura1985，32，： | 1 |
| 5 | Raman spectroscopy employed for the determination of the intermediate phase in polyethylene显示文摘 | CHRISTOPHER C N ROBERT J M BERT J K et al | 1995 | Macromolecules1995，28，8： | 1 |
| 6 | C - reactive protein levels and outcomes after statin therapy 显示文摘 | PAUL M R CHRISTOPHER P C DAVID M | 2005 | N Engl J Med2005，352，： | 1 |
| 7 | Interfacial modification of polystyrene - block - polybutadiene - bloke - polystyrene/magnesium hydroxide composites 显示文摘 | CHRISTOPHER M L PAUL D GRAHAM C | 2003 | Macromol Mater Eng2003，288，： | 1 |
| 8 | Outcomed and clinicopa thologic variables associated with late recurrence after nephrectomy fkr localiged Renal cell carcinoma显示文摘 | SIMON P K CHRISTOPHER J M BRADLEY C L | 2011 | Urology2011，78，5： | 1 |
| 9 | Visible light photoredox catalysis with transition metal complexes:applications in organic synthesis显示文摘 | Christopher K P Danica A R David W C M | 2013 | Chem Rev2013，113，： | 1 |
| 10 | Antithrombot- ic therapies in spine surgery:north American spine society evidence-based clinical guidelines for multidisciplinary spine care 显示文摘 | Christopher M William C Michael I-I | 2009 | Spine J2009，9，12： | 1 |
| 11 | Early involve ment of death associated protein kinase promoter hypermethylation in the carcinogenesis of harrett's esophageal adenocareinoma and its association with clinical progression显示文摘 | Doerthe K Altar A D Christopher C M | 2007 | Ncoplasia2007，9，3： | 1 |
| 12 | Ventilation performan- ce measurement using constant concentration dosing strategy 显示文摘 | Christopher Y C Wan M P Anthony K L | 2004 | Building and Environment2004，39，11： | 1 |
| 13 | Ventilation performance measurement using constant concentration dosing strategy显示文摘 | Christopher Y C Wan M P Anthony K L | 2004 | Building and Environment2004，39，11： | 1 |
| 14 | The antiplasmo-dial activity of norcantharidin analogs 显示文摘 | JOANNA B ADAM M C CHRISTOPHER P G | 2010 | Bioorg Med ChemLett2010，20，22： | 1 |
| 15 | Identification of pathway-selective estrogen receptor ligands that inhibit NF-KB transcriptional activity显示文摘 | Christopher C C Susan C Edward M | 2005 | PNAS2005，102，7： | 1 |
| 16 | Startup and operation of a supercritical carbon dioxide Brayton cycle 显示文摘 | Eric M C Timothy L C Christopher P S | 2014 | Journal of Engineering for Gas Turbines and Power2014，136，： | 1 |
| 17 | Renal impairment and heart failure with preserved ejection fraction early post-myocardial infarction显示文摘AIM:To study if impaired renal function is associated with increased risk of peri-infarct heart failure (HF) in patients with preserved ejection fraction (EF).METHODS:Patients with occluded infarct-related arteries (IRAs) between 1 to 28 d after myocardial infarction (MI) were grouped into chronic kidney disease (CKD) stages based on estimated glomerular filtration rate (eGFR).Rates of early post-MI HF were compared among eGFR groups.Logistic regression was used to explore independent predictors of HF.RESULTS:Reduced eGFR was present in 71.1% of 2160 patients,with significant renal impairment (eGFR < 60 mL/min every 1.73 m2) in 14.8%.The prevalence of HF was higher with worsening renal function:15.5%,17.8% and 29.4% in patients with CKD stages 1,2 and 3 or 4,respectively (P < 0.0001),despite a small absolute difference in mean EF across eGFR groups:48.2 ± 10.0,47.9 ± 11.3 and 46.2 ± 12.1,respectively (P=0.02).The prevalence of HF was again higher with worsening renal function among patients with preserved EF:10.1%,13.6% and 23.6% (P < 0.0001),but this relationship was not significant among patients with depressed EF:27.1%,26.2% and 37.9% (P= 0.071).Moreover,eGFR was an independent correlate of HF in patients with preserved EF (P=0.003) but not in patients with depressed EF (P=0.181).CONCLUSION:A significant proportion of post-MI patients with occluded IRAs have impaired renal function.Impaired renal function was associated with an increased rate of early post-MI HF,the association being strongest in patients with preserved EF.These findings have implications for management of peri-infarct HF. | Vinod Jorapur Gervasio A Lamas Zygmunt P Sadowski Harmony R Reynolds Antonio C Carvalho Christopher E Buller James M Rankin Jean Renkin Philippe Gabriel Steg Harvey D White Carlos Vozzi Eduardo Balcells Michael Ragosta C Edwin Martin Vankeepuram S Srinivas William W Wharton III Staci Abramsky Ana C Mon Shari S Kronsberg Judith S Hochman | 2010 | World Journal of Cardiology2010，2，1： | 1 |
| 18 | Full-scale testing and platform stabilization of a scanning lidarsystem for planetary landing显示文摘 | Andrew C M Allen Christopher Langley Raja Mukherji | 2008 | SPIE2008，，： | 1 |
| 19 | Swalpamycin,a new macrolide antibiotic显示文摘 | CHRISTOPHER M M F JULIA N G SUGATA C | 1987 | The Jour-nal of Aantibiotics1987，11，10： | 1 |
| 20 | Corporate social responsibility reporting in China: Symbol or substance 显示文摘 | Christopher M Qian C | 2014 | Organization Science2014，25，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员